28 Jul Attitudes toward assisted suicide vary among those with Alzheimer’s biomarker
The special interest group pushing assisted suicide in the United States claims that the law narrowly applies only to terminal patients with six months or less to live. They falsely assert that these laws have worked perfectly in the states where they have been legalized the longest, like Oregon, and they lead the American public to believe that they do not support expansion of these laws.
Yet, all we need to do, is look to other countries like Belgium and the Netherlands to see the incremental strategy behind the legalization of assisted suicide and the inevitable expansion of these laws. In 2002, in the Netherlands, euthanasia and assisted suicide were expanded to include any form of “unbearable suffering with no prospect of improvement”. In 2014, Belgium expanded its 2002 Euthanasia Act to include minors.
And now we are seeing a push for assisted suicide to be expanded to patients who are diagnosed with deteriorating neurological conditions like Parkinson’s disease and Alzheimer’s disease. Additionally, we are hearing more regularly the argument that assisted suicide laws should allow for patients to indicate their desires in advance directives, before they become terminally ill.
Recently, “… researchers reported the attitudes toward physician-assisted death among cognitively normal participants recruited from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) study and its companion study, Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN).”
Read more at Helio.com